• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524INT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Bacterial Infection (1735); Death (1802); Hemorrhage/Bleeding (1888); Sepsis (2067); Urinary Tract Infection (2120); No Information (3190); Skin Infection (4544)
Event Date 11/02/2020
Event Type  Death  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer's investigation is completed.
 
Event Description
It was reported through the patient outcome, the patient passed away.No additional information was provided.Privacy laws prohibit the customer from providing information regarding the case.No autopsy was performed.The device was not explanted.
 
Manufacturer Narrative
Section d4, h4: additional information.Section g3: correction.Manufacturer's investigation conclusion: a direct correlation between the reported patient outcome and the heartmate 3 left ventricular assist system (lvas), serial number (b)(4), could not conclusively be determined through this investigation.As privacy laws prohibit the customer from providing information regarding the case, no other information was provided.Heartmate 3 lvas, serial number (b)(4), was not explanted.No product is available for investigation.The heartmate 3 left ventricular assist system instructions for use, lists the adverse events that may be associated with the use of the heartmate 3 lvas, including death.The relevant sections of the device history records for (b)(4) were reviewed.And showed no deviations from manufacturing or quality assurance specifications.No further information was provided.The manufacturer is closing the file on this event.
 
Event Description
It was reported that the patient experienced hypochromic macrocytic anemia requiring a blood transfusion on (b)(6) 2020.The patient's international normalized ration (inr) was 1.74 and hemoglobin was 6.8 g/dl.A colonoscopy and a gastroscopy did not reveal a source of bleeding.A driveline infection and a urinary tract infection led to sepsis despite antibiotics and the patient expired on (b)(6) 2020.
 
Manufacturer Narrative
Updated manufacturer's investigation conclusion: a direct correlation between heartmate 3 left ventricular assist system (lvas), serial number:(b)(6), and the reported bleeding, infections, and patient outcome could not be conclusively established through this evaluation.A specific cause for the bleeding and infections could not be determined; the infections reportedly led to the sepsis, and the patient ultimately expired.Heartmate 3 left ventricular assist system (lvas), serial number: (b)(6), was not explanted for investigation.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) rev.G, is currently available.In section 1 ¿introduction,¿ this ifu lists the adverse events that may be associated with the use of heartmate 3 lvas, including infection (localized, driveline, pump pocket or pseudo pocket), sepsis, bleeding, and death.Section 6 ¿patient care and management¿ (under "anticoagulation") provides information regarding anticoagulation, including recommended international normalized ratio (inr) values, and the suggested anticoagulation modifications in the event there is a risk of bleeding.This section also contains information on controlling infection.Heartmate 3 lvas patient handbook (rev.C): section 4 ¿living with the heartmate 3¿ provides some instructions on how to prevent infection, including keeping the hands and driveline site clean.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key11065633
MDR Text Key223407864
Report Number2916596-2020-06086
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup,Followup
Report Date 08/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/23/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/28/2019
Device Model Number106524INT
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received07/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
-
-